Morpholino

MO2-cldn3c

ID
ZDB-MRPHLNO-210702-1
Name
MO2-cldn3c
Previous Names
None
Target
Sequence
5' - GAATGTCATTTACCAAGTGTCGAGA - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-cldn3c
Expressed Gene Anatomy Figures
atoh7 Fig. 8 from Lu et al., 2020
casp8 Fig. 8 from Lu et al., 2020
cdh11 Fig. 8 from Lu et al., 2020
cdkn1a Fig. 8 from Lu et al., 2020
cldn3c Fig. 8 from Lu et al., 2020
crx Fig. 8 from Lu et al., 2020
hlx1 Fig. 8 from Lu et al., 2020
insm1a Fig. 8 from Lu et al., 2020
myl7 Fig. 8 from Lu et al., 2020
neurod1 Fig. 8 from Lu et al., 2020
pcdh17 Fig. 8 from Lu et al., 2020
sox9b Fig. 8 from Lu et al., 2020
tp53 Fig. 8 from Lu et al., 2020
Phenotype
Phenotype resulting from MO2-cldn3c
Phenotype Fish Figures
eye sox9b expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye Ab1-hlx1 labeling decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye cldn3c expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye atoh7 expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye hlx1 expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye crx expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye ab2-crx labeling decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye myl7 expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye neurod1 expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye cdh11 expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye ab1-neurod1 labeling decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye insm1a expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye pcdh17 expression decreased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye decreased area, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
eye decreased size, abnormal WT + MO2-cldn3c Fig. S2 from Lu et al., 2020
eye tp53 expression increased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye casp8 expression increased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
eye cdkn1a expression increased amount, abnormal WT + MO2-cldn3c Fig. 8 from Lu et al., 2020
hyaloid vessel decreased amount, abnormal zf531Tg + MO2-cldn3c Fig. 6 from Lu et al., 2020
hyaloid vessel decreased size, abnormal zf531Tg + MO2-cldn3c Fig. 6 from Lu et al., 2020
hyaloid vessel unlumenized, abnormal zf531Tg + MO2-cldn3c Fig. 6,  Fig. 7 from Lu et al., 2020
pericardium edematous, abnormal WT + MO2-cldn3c Fig. S2 from Lu et al., 2020
retina decreased size, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
retina decreased thickness, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
retina apoptotic process increased occurrence, abnormal zf531Tg + MO2-cldn3c Fig. 5 from Lu et al., 2020
retina cell population proliferation decreased process quality, abnormal zf531Tg + MO2-cldn3c Fig. 5 from Lu et al., 2020
retina layer formation decreased process quality, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
retinal ganglion cell layer decreased thickness, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
retinal inner plexiform layer decreased thickness, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
retinal neural layer decreased thickness, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
retinal outer nuclear layer decreased thickness, abnormal WT + MO2-cldn3c Fig. 4 from Lu et al., 2020
swim bladder absent, abnormal WT + MO2-cldn3c Fig. S2 from Lu et al., 2020
Phenotype of all Fish created by or utilizing MO2-cldn3c
Phenotype Fish Conditions Figures
eye decreased size, abnormal WT + MO2-cldn3c standard conditions Fig. S2 from Lu et al., 2020
eye myl7 expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye casp8 expression increased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
retinal neural layer decreased thickness, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
retina decreased size, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
eye Ab1-hlx1 labeling decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye ab1-neurod1 labeling decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye crx expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye cldn3c expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye sox9b expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye decreased area, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
retinal outer nuclear layer decreased thickness, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
eye hlx1 expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
retinal ganglion cell layer decreased thickness, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
pericardium edematous, abnormal WT + MO2-cldn3c standard conditions Fig. S2 from Lu et al., 2020
eye tp53 expression increased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye insm1a expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye cdh11 expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
eye atoh7 expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
swim bladder absent, abnormal WT + MO2-cldn3c standard conditions Fig. S2 from Lu et al., 2020
retina layer formation decreased process quality, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
eye ab2-crx labeling decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
retinal inner plexiform layer decreased thickness, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
eye neurod1 expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
retina decreased thickness, abnormal WT + MO2-cldn3c standard conditions Fig. 4 from Lu et al., 2020
eye cdkn1a expression increased amount, abnormal WT + MO2-cldn3c control Fig. 8 from Lu et al., 2020
eye pcdh17 expression decreased amount, abnormal WT + MO2-cldn3c standard conditions Fig. 8 from Lu et al., 2020
retina cell population proliferation decreased process quality, abnormal zf531Tg + MO2-cldn3c standard conditions Fig. 5 from Lu et al., 2020
hyaloid vessel unlumenized, abnormal zf531Tg + MO2-cldn3c standard conditions Fig. 6,  Fig. 7 from Lu et al., 2020
hyaloid vessel decreased amount, abnormal zf531Tg + MO2-cldn3c standard conditions Fig. 6 from Lu et al., 2020
hyaloid vessel decreased size, abnormal zf531Tg + MO2-cldn3c standard conditions Fig. 6 from Lu et al., 2020
retina apoptotic process increased occurrence, abnormal zf531Tg + MO2-cldn3c standard conditions Fig. 5 from Lu et al., 2020
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.